| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.09 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.086 | 0.6 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.081 | 0.6 |